Selective Safety Data Collection in Clinical Studies of Oncology Drugs for Marketing Approval in the United States. regsci [Internet]. 2017 Aug. 8 [cited 2024 Sep. 16];5(2):36-44. Available from: https://regsci-ojs-tamu.tdl.org/regsci/article/view/67